Citalopram Hydrobromide

Premature Ejaculation, Bulimia Nervosa, Panic Disorder + 7 more

Treatment

1 FDA approval

20 Active Studies for Citalopram Hydrobromide

What is Citalopram Hydrobromide

Citalopram

The Generic name of this drug

Treatment Summary

Citalopram is an antidepressant medication that belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is commonly used to treat depression and is available in tablet and solution forms. Citalopram was first approved by the FDA in 1998 under the brand name Celexa.

Celexa

is the brand name

image of different drug pills on a surface

Citalopram Hydrobromide Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Celexa

Citalopram

1998

424

Approved as Treatment by the FDA

Citalopram, also known as Celexa, is approved by the FDA for 1 uses like Depression .

Depression

Helps manage Depression

Effectiveness

How Citalopram Hydrobromide Affects Patients

Citalopram is a type of antidepressant that helps to manage symptoms of depression, anxiety, eating disorders, and obsessive-compulsive disorder. It works by blocking the uptake of serotonin, a chemical in the brain responsible for regulating mood, behavior, reward, and other functions. It usually takes 1-4 weeks for citalopram to start working and 8-12 weeks for the full effects to be felt. In addition to blocking serotonin uptake, citalopram can also reduce the number of norepinephrine receptors in the brain. It does not affect monoamine oxidase.

How Citalopram Hydrobromide works in the body

Citalopram works by blocking the reuptake of serotonin in the brain. It does this by targeting a specific protein, the serotonin transporter, to stop it from taking serotonin out of the synapse. Citalopram does not have a strong effect on other types of receptors, so it does not cause some of the side effects seen with other antidepressant drugs.

When to interrupt dosage

The prescribed dosage of Citalopram Hydrobromide is contingent upon the specified condition, such as Obsessive-Compulsive Disorder, Premenstrual Dysphoric Disorder and Diabetic Neuropathy. The quantity of dosage fluctuates, depending on the technique of delivery (e.g. Tablet - Oral or Tablet) featured in the table beneath.

Condition

Dosage

Administration

Obsessive-Compulsive Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Social Anxiety Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Generalized Anxiety Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Diabetic Neuropathy

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Anorexia Nervosa

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Premature Ejaculation

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Post Traumatic Stress Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Bulimia Nervosa

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Depression

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Panic Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Warnings

Citalopram Hydrobromide has three contraindications and should not be employed together with the circumstances detailed in the subsequent table.

Citalopram Hydrobromide Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Citalopram may interact with Pulse Frequency

There are 20 known major drug interactions with Citalopram Hydrobromide.

Common Citalopram Hydrobromide Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Citalopram.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Citalopram.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Citalopram.

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Citalopram.

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Citalopram.

Citalopram Hydrobromide Toxicity & Overdose Risk

The toxic dose of citalopram in humans is 56mg/kg and 179 mg/kg in mice. Symptoms of overdose include dizziness, sweating, nausea, vomiting, trembling, sleepiness, and an increased heart rate. In rare cases, symptoms may include amnesia, confusion, coma, seizures, shallow breathing, and a bluish skin color. If someone overdoses on citalopram, medical professionals should ensure the person is breathing properly and monitored for changes in their heart rate and other vital signs. Treatments for citalopram overdose include lavage and activated charcoal, however dialysis and other forms of filtering are

image of a doctor in a lab doing drug, clinical research

Citalopram Hydrobromide Novel Uses: Which Conditions Have a Clinical Trial Featuring Citalopram Hydrobromide?

954 active clinical trials are investigating the potential of Citalopram Hydrobromide to alleviate Panic Disorder, Obsessive-Compulsive Disorder and Depression.

Condition

Clinical Trials

Trial Phases

Obsessive-Compulsive Disorder

66 Actively Recruiting

Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1

Post Traumatic Stress Disorder

239 Actively Recruiting

Not Applicable, Early Phase 1, Phase 3, Phase 4, Phase 2, Phase 1

Panic Disorder

13 Actively Recruiting

Not Applicable

Bulimia Nervosa

0 Actively Recruiting

Depression

305 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Premature Ejaculation

0 Actively Recruiting

Diabetic Neuropathy

5 Actively Recruiting

Not Applicable, Phase 1, Phase 2

Social Anxiety Disorder

15 Actively Recruiting

Not Applicable

Anorexia Nervosa

0 Actively Recruiting

Generalized Anxiety Disorder

7 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Citalopram Hydrobromide Reviews: What are patients saying about Citalopram Hydrobromide?

5

Patient Review

6/29/2022

Citalopram Hydrobromide for Depression

I've been taking citalopram for four months now, and they're really working well for me. I had a few side effects at first that made me feel nauseous, but my doctor suggested taking them with my evening meal and that solved the problem. Now I'm able to sleep and go to work again without any issues.

4.3

Patient Review

3/17/2022

Citalopram Hydrobromide for "Change of Life" Signs

I used this treatment four years ago and it was effective.

4

Patient Review

3/22/2022

Citalopram Hydrobromide for Depression

This treatment really helped to get my emotions under control. I would highly recommend it for anyone struggling with sadness or anger.

4

Patient Review

6/2/2022

Citalopram Hydrobromide for Major Depressive Disorder

I've dealt with depression for a long time, and this was one of the better medications I tried. No weight gain, decent sleep, and good days mixed in with the bad. The only downside is that it stopped being effective after a while.

4

Patient Review

3/20/2022

Citalopram Hydrobromide for Anxiousness associated with Depression

I've been on this medication for four weeks and I have definitely noticed an improvement in my mood. That being said, I have also experienced some side effects like dizziness and headaches.

2.7

Patient Review

3/11/2022

Citalopram Hydrobromide for Depression

I didn't find this medication effective at all and actually felt worse after taking it. The side effects were also pretty bad; I was constantly tired and had panic attacks.

2.3

Patient Review

4/29/2022

Citalopram Hydrobromide for Anxiousness associated with Depression

I don't think these work as well as people say they do.

1

Patient Review

9/24/2022

Citalopram Hydrobromide for Panic Disorder

I felt like this medication was burning me from the inside out. I had terrible tremors, shaking, and muscle aches. This also made my anxiety much worse and I felt constantly cold and shivering.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about citalopram hydrobromide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Xanax the same as citalopram?

"Celexa and Xanax are not the same medication, even though you might experience some of the same side effects while taking them. Celexa is a selective serotonin reuptake inhibitor (SSRI), while Xanax is a benzodiazepine."

Answered by AI

What are citalopram hydrobromide used for?

"Citalopram is used as an antidepressant to treat major depressive disorder by increasing serotonin activity in the brain."

Answered by AI

Is citalopram hydrobromide for anxiety?

"Celexa is a selective serotonin reuptake inhibitor (SSRI) and Xanax is a benzodiazepine.

Celexa works by increasing the level of serotonin in the brain while Xanax works by affecting certain chemicals in the brain that may become unbalanced and cause anxiety."

Answered by AI

What are the most common side effects of citalopram?

"The following effects may occur: nausea, dry mouth, loss of appetite, tiredness, drowsiness, sweating, blurred vision, and yawning. If you experience any of these effects for an extended period of time, or if they worsen, consult your doctor or pharmacist."

Answered by AI

Clinical Trials for Citalopram Hydrobromide

Image of Columbia University Irving Medical Center in New York, United States.

Mindfulness-Based Exposure Therapy for PTSD After Cardiac Arrest

18 - 81
All Sexes
New York, NY

The goal of this clinical trial is to learn if a new therapy called Acceptance- and Mindfulness-Based Exposure Therapy (AMBET) helps treat post-traumatic stress disorder (PTSD) in people who survived a cardiac arrest. This study will compare AMBET to another psychotherapy treatment called Present Centered Therapy (PCT) to see which therapy is more effective in treating PTSD. The main questions it aims to answer are: Does AMBET reduce PTSD symptoms in survivors of cardiac arrest? How do the benefits of AMBET compare to PCT? Participants will: * Be randomly assigned to receive either AMBET or PCT * Attend 12 hours of individual psychotherapy sessions over about 12 weeks * Complete short weekly surveys about their mood and behaviors online * Wear a Fitbit device to track sleep and activity during the study * Do brief homework assignments between sessions

Waitlist Available
Has No Placebo

Columbia University Irving Medical Center

Yuval Neria, PhD

Image of The University of Texas Health Science Center at Houston in Houston, United States.

Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder

7 - 14
All Sexes
Houston, TX

One of the most common and widely disseminated trauma treatments is Trauma Focused Cognitive Behavioral Therapy (TF-CBT). TF-CBT is a therapist-led, structured and sequential intervention, with treatment organized around P.R.A.C.T.I.C.E. (Psychoeducation, Parent training, Relaxation, Affective Regulation, Cognitive Coping, Trauma Narrative, In-Vivo Exposure, Cognitive Reprocessing, and Enhancing Safety) components. Stepped Care Cognitive Behavioral Therapy for Children after Trauma (SC-CBT-CT) is an alternative delivery system that incorporates the best available evidence on the treatment of childhood Post-traumatic Stress Disorder (PTSD) within a stepped care model and utilizes task-shifting with caregiver involvement, which engages caregivers in actively helping their children. Stepped care approaches are characterized by a personalized approach to care in which a lower intensity (i.e., fewer number of sessions) intervention is initially provided before the child is reevaluated or ''stepped up'' for additional care should symptoms persist. The goal of this study is to assess a personalized modification of SC-CBT-CT for Latino families (pSC-CBT-CT). The hypothesis is that personalizing SC-CBT-CT will improve outcomes for Latino children.

Waitlist Available
Has No Placebo

The University of Texas Health Science Center at Houston

Leslie K Taylor, PhD

Image of The University of Texas Health Science Center at Houston in Houston, United States.

Personalized Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder

7 - 14
All Sexes
Houston, TX

One of the most common and widely disseminated trauma treatments is Trauma Focused Cognitive Behavioral Therapy (TF-CBT). TF-CBT is a therapist-led, structured and sequential intervention, with treatment organized around P.R.A.C.T.I.C.E. (Psychoeducation, Parent training, Relaxation, Affective Regulation, Cognitive Coping, Trauma Narrative, In-Vivo Exposure, Cognitive Reprocessing, and Enhancing Safety) components. Stepped Care Cognitive Behavioral Therapy for Children after Trauma (SC-CBT-CT) is an alternative delivery system that incorporates the best available evidence on the treatment of childhood Post-traumatic Stress Disorder (PTSD) within a stepped care model and utilizes task-shifting with caregiver involvement, which engages caregivers in actively helping their children. Stepped care approaches are characterized by a personalized approach to care in which a lower intensity (i.e., fewer number of sessions) intervention is initially provided before the child is reevaluated or ''stepped up'' for additional care should symptoms persist. The goal of this study is to assess a personalized modification of SC-CBT-CT for Latino families (pSC-CBT-CT). The hypothesis is that personalizing SC-CBT-CT will improve outcomes for Latino children.

Waitlist Available
Has No Placebo

The University of Texas Health Science Center at Houston

Leslie K Taylor, PhD

Image of University of Michigan in Ann Arbor, United States.

Virtual Reality for Depression in Multiple Sclerosis

18+
All Sexes
Ann Arbor, MI

This trial explores the use of immersive virtual reality (VR) nature-based experiences as a supplementary treatment for depression in individuals with progressive multiple sclerosis (MS). This study will evaluate the feasibility and efficacy of at-home VR deployment using the Apple Vision Pro, an advanced device that offers enhanced resolution, immersion, and usability compared to earlier VR systems. The study hypotheses include: * The integration of VR nature-based experiences with standard care will be feasible, acceptable, and will result in greater reductions in depressive symptoms compared to standard care or VR-only interventions. * The integration of VR nature-based experiences with standard care will result in greater reductions in stress and anxiety, better sleep, less insomnia, and improved fatigue compared to standard care alone or VR-only interventions.

Recruiting
Has No Placebo

University of Michigan

Hala Darwish, PhD

Apple Inc.

Have you considered Citalopram Hydrobromide clinical trials?

We made a collection of clinical trials featuring Citalopram Hydrobromide, we think they might fit your search criteria.
Go to Trials
Image of Medical University of South Carolina (MUSC), Brain Stimulation Laboratory Institute of Psychiatry in Charleston, United States.

Mindfulness Training for Depression

18 - 70
All Sexes
Charleston, SC

This NIH-funded single-arm pilot tests the feasibility, acceptability, and preliminary effects of embedding brief guided mindfulness practice (via the Healthy Minds smartphone app) into the inter-session intervals of clinically administered accelerated intermittent theta-burst stimulation (aiTBS) for major depressive disorder (MDD). Participants receive aiTBS as standard clinical care at MUSC; the research intervention is daily guided mindfulness practice during the aiTBS course. Outcomes include feasibility/acceptability, changes in state mindfulness and hedonic tone (Day 0 to Day 5), perceived ease of meditation, trait mindfulness at 4 and 12 weeks, and durability of antidepressant response (PHQ-9) at 4 and 12 weeks.

Waitlist Available
Has No Placebo

Medical University of South Carolina (MUSC), Brain Stimulation Laboratory Institute of Psychiatry

Clayton Olash, MD

Have you considered Citalopram Hydrobromide clinical trials?

We made a collection of clinical trials featuring Citalopram Hydrobromide, we think they might fit your search criteria.
Go to Trials
Image of University of South Florida in Tampa, United States.

Web-Based Program for Parenting Stress

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to evaluate the feasibility, usability, and preliminary benefits of implementing ACT Together for parents of children with disabilities in pediatric outpatient clinics. ACT Together includes six self-paced, web-based modules and brief weekly one-on-one coaching sessions led by a trained occupational therapist. The program is based on acceptance and commitment therapy (ACT), which teaches practical skills to help people handle stress and difficult thoughts or feelings while taking steps toward what matters to them. The main questions this study aims to answer are: * Can parents and occupational therapists complete the study activities as planned (e.g., module completion, coaching sessions, and surveys)? * Is the program usable and acceptable/appropriate/feasible to implement in this setting? * Do parents show improvements in mental health and coping-related outcomes after participating in the program? * What are the experiences and perspectives of parents and therapists regarding the program? Parents as participants will: * Complete six self-paced web-based modules and brief weekly individual coaching sessions with a trained occupational therapist. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experiences and perspectives on the program. Occupational therapists as participants will: * Complete therapist training materials and deliver brief individual coaching sessions to parent participants, including completing a post-session checklist. * Complete brief online questionnaires before starting and after delivering the program. * Take part in one online interview about their experiences and perspectives on the program.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han, PhD

Image of Worcester Recovery Center and Hospital in Worcester, United States.

Changing Lives and Changing Outcomes-9 for Serious Mental Illness

18+
All Sexes
Worcester, MA

People with serious mental illness (depression, bipolar, and schizophrenia spectrum disorders) have high rates of repeated criminal legal involvement and psychiatric hospitalizations. Longstanding research shows that in addition to treating clients' symptoms of mental illness, targeting risk factors for legal involvement can help reduce their chances of future incarcerations. Because hospitals are becoming increasingly forensic, treatment programs that address both mental illness and risk factors for legal involvement may be especially helpful in a state hospital setting, like Worcester Recovery Center and Hospital (WRCH). This treatment study offers an adjunctive 9-session intervention, Changing Lives and Changing Outcomes-9 (CLCO-9), for patients at WRCH; this program is designed to help people with serious mental illness who are involved in the legal system increase their awareness of their mental health and reduce their chances of future legal involvement. The investigators are proposing a treatment study testing the use of the CLCO-9 group intervention with patients with serious mental illness with current or previous criminal legal involvement at Worcester Recovery Center and Hospital (WRCH). The study has three aims: 1. Evaluate feasibility, fidelity, and patient satisfaction during the implementation of the CLCO-9 group treatment at WRCH 2. Evaluate CLCO-9's effectiveness on improving patient's self-reported mental health, and behavioral indicators of mental health and risk factors for legal involvement 3. Explore changes in WRCH clinicians' knowledge and attitudes about treating risk factors for criminal legal involvement. To test these aims, the research team will employ a two-phase study. In the first phase, the researchers will implement the intervention and make necessary adjustments to maximize the success of the implementation. In the second phase, the researchers will evaluate the treatment program's effectiveness in producing change from pre- to post-treatment. All patient participants in this study will receive the intervention. The projected sample size is about 20 treatment completers and 4 to 8 group leaders.

Waitlist Available
Has No Placebo

Worcester Recovery Center and Hospital

Faith Scanlon, PhD

Have you considered Citalopram Hydrobromide clinical trials?

We made a collection of clinical trials featuring Citalopram Hydrobromide, we think they might fit your search criteria.
Go to Trials